Literature DB >> 7720336

L-arginine increases exhaled nitric oxide in normal human subjects.

S A Kharitonov1, G Lubec, B Lubec, M Hjelm, P J Barnes.   

Abstract

1. Endogenous nitric oxide plays an important physiological role and is synthesized by several isoforms of nitric oxide synthase from the semiessential amino acid L-arginine. Nitric oxide is detectable in the exhaled air of normal individuals and may be used to monitor the formation of nitric oxide in the respiratory tract. 2. We have investigated the effect of orally administered L-arginine (0.05, 0.1, 0.2 g/kg) compared with matched placebo on the concentration of nitric oxide in the exhaled air in 23 normal individuals. 3. L-Arginine caused significant increases in the concentration of nitric oxide in exhaled air at doses of 0.1 and 0.2 mg/kg, which was maximal 2 h after administration. This was associated with an increase in the concentration of L-arginine and nitrate in plasma. There were no significant changes in heart rate, blood pressure or forced expiratory volume in 1 s. 4. These results suggest that an increase in the amount of substrate for nitric oxide synthase can increase the formation of endogenous nitric oxide. This may have therapeutic relevance in diseases in which there is defective production of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7720336     DOI: 10.1042/cs0880135

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  26 in total

Review 1.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

Review 2.  Exhaled nitric oxide: a new lung function test.

Authors:  P J Barnes; S A Kharitonov
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

3.  Exogenous L-arginine does not affect angiotensin II-induced renal vasoconstriction in man.

Authors:  M Wolzt; A Ugurluoglu; L Schmetterer; G Dorner; G Zanaschka; C Mensik; H G Eichler
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

Review 4.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

5.  Acute inhalation of cigarette smoke increases lower respiratory tract nitric oxide concentrations.

Authors:  D C Chambers; W S Tunnicliffe; J G Ayres
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

6.  l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells.

Authors:  D Winnica; L G Que; C Baffi; H Grasemann; K Fiedler; Z Yang; E Etling; K Wasil; S E Wenzel; B Freeman; F Holguin
Journal:  Clin Exp Allergy       Date:  2016-10-04       Impact factor: 5.018

7.  L-arginine reverses cigarette-induced reduction of fractional exhaled nitric oxide in asthmatic smokers.

Authors:  C T Bruce; D Zhao; D H Yates; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2009-10-18       Impact factor: 4.473

Review 8.  Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives.

Authors:  Harm Maarsingh; Johan Zaagsma; Herman Meurs
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

9.  An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype.

Authors:  Fernando Holguin; Suzy A A Comhair; Stanley L Hazen; Robert W Powers; Sumita S Khatri; Eugene R Bleecker; William W Busse; William J Calhoun; Mario Castro; Anne M Fitzpatrick; Benjamin Gaston; Elliot Israel; Nizar N Jarjour; Wendy C Moore; Stephen P Peters; W Gerald Teague; Kian Fan Chung; Serpil C Erzurum; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

10.  Exhaled nitric oxide in diagnosis and management of respiratory diseases.

Authors:  Abdullah A Abba
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.